Head and Neck Cancer Registry (LORHAN)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

26000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-08-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers

NCT05483374

Head and Neck Cancer Nasopharynx Cancer Nasal Cavity and Paranasal Sinus Cancer +2 more

RECRUITING

A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

NCT00116909

Locally Recurrent or Metastatic Cancer of the Head and Neck Must Have Failed First-Line Therapy

COMPLETED PHASE2

Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck

NCT03083873

Squamous Cell Carcinoma of the Head and Neck

COMPLETED PHASE2

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

NCT00458978

Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Laryngeal Verrucous Carcinoma +20 more

COMPLETED PHASE2

Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

NCT00022594

Head and Neck Cancer

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Head and Neck Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with head and neck cancer

Therapy for head and neck cancer

Intervention Type OTHER

radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Therapy for head and neck cancer

radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node metastasis from unknown origin
* Scheduled to receive radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy
* Written informed consent

Exclusion Criteria

* Registry participation does not exclude participation in clinical trials.
* Patients scheduled to receive or who have received surgery are eligible for Registry participation as long as they are also scheduled to receive medical therapy.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No